Literature DB >> 27107685

Factors associated with severity in invasive community-acquired Staphylococcus aureus infections in children: a prospective European multicentre study.

M Gijón1, M Bellusci1, B Petraitiene1, A Noguera-Julian1, V Zilinskaite1, P Sanchez Moreno1, J Saavedra-Lozano1, D Glikman1, M Daskalaki1, P Kaiser-Labusch1, O Falup-Pecurariu1, C Montagnani1, L Prieto1, A Gené1, G Trumpulyte1, I Kulecnikova1, J A Lepe1, E Cercenado1, R Kudinsky1, A Makri1, H I Huppertz1, L Bleotu1, P Cocchi1, P García-Hierro1, A Vitkauskiene1, C Fortuny1, V Zukovskaja1, O Neth1, M Santos1, A Rokney1, M Petra1, R Lixandru1, L Galli1, S Guillén1, F Chaves1, P Rojo Conejo2.   

Abstract

Staphylococcus aureus is the main pathogen responsible for bone and joint infections worldwide and is also capable of causing pneumonia and other invasive severe diseases. Panton-Valentine leukocidin (PVL) and methicillin-resistant S. aureus (MRSA) have been studied as factors related with severity in these infections. The aims of this study were to describe invasive community-acquired S. aureus (CA-SA) infections and to analyse factors related to severity of disease. Paediatric patients (aged 0-16 years) who had a CA-SA invasive infection were prospectively recruited from 13 centres in 7 European countries. Demographic, clinical and microbiological data were collected. Severe infection was defined as invasive infection leading to death or admission to intensive care due to haemodynamic instability or respiratory failure. A total of 152 children (88 boys) were included. The median age was 7.2 years (interquartile range, 1.3-11.9). Twenty-six (17%) of the 152 patients had a severe infection, including 3 deaths (2%). Prevalence of PVL-positive CA-SA infections was 18.6%, and 7.8% of the isolates were MRSA. The multivariate analysis identified pneumonia (adjusted odds ratio (aOR) 13.39 (95% confidence interval (CI) 4.11-43.56); p 0.008), leukopenia at admission (<3000/mm(3)) (aOR 18.3 (95% CI 1.3-259.9); p 0.03) and PVL-positive infections (aOR 4.69 (95% CI 1.39-15.81); p 0.01) as the only factors independently associated with severe outcome. There were no differences in MRSA prevalence between severe and nonsevere cases (aOR 4.30 (95% CI 0.68- 28.95); p 0.13). Our results show that in European children, PVL is associated with more severe infections, regardless of methicillin resistance.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Children; Community-acquired Staphylococcus aureus; Methicillin resistance; Panton-Valentine leukocidin; Severe infections

Mesh:

Substances:

Year:  2016        PMID: 27107685     DOI: 10.1016/j.cmi.2016.04.004

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  20 in total

1.  Methicillin-sensible Staphylococcus aureus causing endocarditis, with cerebral and orthopaedic complications, in a 17-month-old child with no risk factor.

Authors:  Guillaume Geslain; Clara Bourgade; Maryline Chomton; Fleur Le Bourgeois
Journal:  BMJ Case Rep       Date:  2018-10-12

2.  Survey of Staphylococcus aureus in a general pediatric population and focus on isolates with three clinically relevant toxin-encoding genes.

Authors:  Anne Filleron; Sarah Beauregard-Birba; Thibault Mura; Fabien Aujoulat; Anne Laure Michon; Michel Rodière; Tu Anh Tran; Eric Jeziorski; Hélène Marchandin
Journal:  World J Pediatr       Date:  2018-02-13       Impact factor: 2.764

3.  Distinguishing Kingella kingae from Pyogenic Acute Septic Arthritis in Young Portuguese Children.

Authors:  Catarina Gouveia; Ana Subtil; Susana Norte; Joana Arcangelo; Madalena Almeida Santos; Rita Corte-Real; Maria João Simões; Helena Canhão; Delfin Tavares
Journal:  Microorganisms       Date:  2022-06-16

4.  Molecular Characteristics, Antimicrobial Resistance and Virulence Gene Profiles of Staphylococcus aureus Isolates from Wuhan, Central China.

Authors:  Yu Fu; Mengyuan Xiong; Xuehan Li; Junying Zhou; Xiao Xiao; Fang Fang; Xiaohuan Cheng; Yingbang Le; Yirong Li
Journal:  Infect Drug Resist       Date:  2020-06-30       Impact factor: 4.003

5.  A Cross-Sectional Study of Colonization Rates with Methicillin-Resistant Staphylococcus aureus (MRSA) and Extended-Spectrum Beta-Lactamase (ESBL) and Carbapenemase-Producing Enterobacteriaceae in Four Swiss Refugee Centres.

Authors:  Rein Jan Piso; Roman Käch; Roxana Pop; Daniela Zillig; Urs Schibli; Stefano Bassetti; Dominik Meinel; Adrian Egli
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

Review 6.  Molecular epidemiology of the community-associated methicillin-resistant staphylococcus aureus clones: a synthetic review.

Authors:  Lia Monica Junie; Ionuţ Isaia Jeican; Luminiţa Matroş; Stanca Lucia Pandrea
Journal:  Clujul Med       Date:  2018-01-15

7.  Spontaneous community-acquired PVL-producing Staphylococcus aureus mediastinitis in an immunocompetent adult - a case report.

Authors:  Josselin Brisset; Thomas Daix; Jérémy Tricard; Bruno Evrard; Philippe Vignon; Olivier Barraud; Bruno François
Journal:  BMC Infect Dis       Date:  2020-05-19       Impact factor: 3.090

8.  Prediction of Adverse Outcomes in Pediatric Acute Hematogenous Osteomyelitis.

Authors:  Zaid Alhinai; Morvarid Elahi; Sangshin Park; Bill Foo; Brian Lee; Kimberle Chapin; Michael Koster; Pablo J Sánchez; Ian C Michelow
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

9.  Prevalence and characteristics of methicillin-resistant Staphylococcus aureus in community residents of Japan.

Authors:  Fumi Yamasaki; Seisho Takeuchi; Yoshio Uehara; Masahide Matsushita; Kazumi Arise; Norihito Morimoto; Hiromi Seo
Journal:  J Gen Fam Med       Date:  2018-03-09

Review 10.  Panton-valentine leukocidin Staphylococcus aureus severe infection in an infant: a case report and a review of the literature.

Authors:  Massimo Luca Castellazzi; Samantha Bosis; Irene Borzani; Claudia Tagliabue; Raffaella Pinzani; Paola Marchisio; Giada Maria di Pietro
Journal:  Ital J Pediatr       Date:  2021-07-17       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.